Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 29 articles: HTML format

Single Articles

September 2021
1. 
   Correction for Jeon et al., A set of NF-kappaB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed    
   
   
   May 2021
2. TIEN JC, Chugh S, Goodrum AE, Cheng Y, et al
   AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   March 2021
3. YANG L, Yan X, Chen J, Zhan Q, et al
   Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
4. BROWNLIE D, Scharenberg M, Mold JE, Hard J, et al
   Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   February 2021
5. JIMENEZ-SANCHEZ J, Bosque JJ, Jimenez Londono GA, Molina-Garcia D, et al
   Evolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   January 2021
6. CHIBAYA L, Karim B, Zhang H, Jones SN, et al
   Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
7. XIAO Y, Lin FT, Lin WC
   ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   December 2020
8. HOJ JP, Mayro B, Pendergast AM
   The ABL2 kinase regulates an HSF1-dependent transcriptional program required for lung adenocarcinoma brain metastasis.
   Proc Natl Acad Sci U S A. 2020 Dec 14. pii: 2007991117.
   PubMed     Abstract available
   
   
   
9. MAYRHOFER JE, Enzler F, Feichtner A, Rock R, et al
   Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies.
   Proc Natl Acad Sci U S A. 2020;117:31105-31113.
   PubMed     Abstract available
   
   
   November 2020
10. VASSEL FM, Bian K, Walker GC, Hemann MT, et al
    Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer.
    Proc Natl Acad Sci U S A. 2020 Nov 3. pii: 2016067117.
    PubMed     Abstract available
    
    
    September 2020
11. ESTEBAN-BURGOS L, Wang H, Nieto P, Zheng J, et al
    Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.
    Proc Natl Acad Sci U S A. 2020;117:24415-24426.
    PubMed     Abstract available
    
    
    
12. YING L, Du L, Zou R, Shi L, et al
    Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.
    Proc Natl Acad Sci U S A. 2020 Sep 17. pii: 2006212117.
    PubMed     Abstract available
    
    
    August 2020
13. LIU C, Xu X, Han L, Wan X, et al
    LRCH1 deficiency enhances LAT signalosome formation and CD8(+) T cell responses against tumors and pathogens.
    Proc Natl Acad Sci U S A. 2020;117:19388-19398.
    PubMed     Abstract available
    
    
    July 2020
14. SMITH HW, Yang L, Ling C, Walsh A, et al
    An ErbB2 splice variant lacking exon 16 drives lung carcinoma.
    Proc Natl Acad Sci U S A. 2020 Jul 29. pii: 2007474117.
    PubMed     Abstract available
    
    
    March 2020
15. WANG X, Yang X, Zhang C, Wang Y, et al
    Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy.
    Proc Natl Acad Sci U S A. 2020;117:6640-6650.
    PubMed     Abstract available
    
    
    
16. NA TY, Schecterson L, Mendonsa AM, Gumbiner BM, et al
    The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
    Proc Natl Acad Sci U S A. 2020;117:5931-5937.
    PubMed     Abstract available
    
    
    
17. PHILLIPS JW, Pan Y, Tsai BL, Xie Z, et al
    Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
    Proc Natl Acad Sci U S A. 2020;117:5269-5279.
    PubMed     Abstract available
    
    
    
18. TANG MS
    Reply to Young and Scott: Nicotine and nicotinic acetylcholine receptor mutations in electronic-cigarette smoke lung carcinogenicity.
    Proc Natl Acad Sci U S A. 2020;117:4462-4463.
    PubMed    
    
    
    
19. JIANG H, Cao HJ, Ma N, Bao WD, et al
    Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
    Proc Natl Acad Sci U S A. 2020;117:4770-4780.
    PubMed     Abstract available
    
    
    
20. KESAVAN R, Fromel T, Zukunft S, Laban H, et al
    Cyp2c44 regulates prostaglandin synthesis, lymphangiogenesis, and metastasis in a mouse model of breast cancer.
    Proc Natl Acad Sci U S A. 2020 Mar 2. pii: 1921381117.
    PubMed     Abstract available
    
    
    February 2020
21. BRANDT AC, McNally L, Lorimer EL, Unger B, et al
    Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy.
    Proc Natl Acad Sci U S A. 2020;117:3627-3636.
    PubMed     Abstract available
    
    
    
22. VITOS-FALEATO J, Real SM, Gutierrez-Prat N, Villanueva A, et al
    Requirement for epithelial p38alpha in KRAS-driven lung tumor progression.
    Proc Natl Acad Sci U S A. 2020;117:2588-2596.
    PubMed     Abstract available
    
    
    January 2020
23. NAIR P
    QnAs with Sangeeta N. Bhatia.
    Proc Natl Acad Sci U S A. 2020;117:1243-1245.
    PubMed    
    
    
    
24. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
    Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
    Proc Natl Acad Sci U S A. 2020;117:1119-1128.
    PubMed     Abstract available
    
    
    
25. WINKLER I, Bitter C, Winkler S, Weichenhan D, et al
    Identification of Ppargamma-modulated miRNA hubs that target the fibrotic tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:454-463.
    PubMed     Abstract available
    
    
    November 2019
26. LINETTE GP, Becker-Hapak M, Skidmore ZL, Baroja ML, et al
    Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Proc Natl Acad Sci U S A. 2019 Nov 4. pii: 1906026116.
    PubMed     Abstract available
    
    
    September 2019
27. YIN Y, Xie CM, Li H, Tan M, et al
    The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
    Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1905973116.
    PubMed     Abstract available
    
    
    
28. LIM SB, Yeo T, Lee WD, Bhagat AAS, et al
    Addressing cellular heterogeneity in tumor and circulation for refined prognostication.
    Proc Natl Acad Sci U S A. 2019;116:17957-17962.
    PubMed     Abstract available
    
    
    August 2019
29. SCHMIDT L, Eskiocak B, Kohn R, Dang C, et al
    Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation.
    Proc Natl Acad Sci U S A. 2019;116:17460-17469.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: